Has Thomas Bradbury, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,921,673 in general payments to Thomas Bradbury, MD across 146 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Bradbury, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Bradbury, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Bradbury, MD

Adult Reconstructive Orthopaedic Surgery · Atlanta, GANPI 1720019698

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,868,364 of the $1,921,673 with a category attached, or 97.2%. Zimmer Biomet accounts for 97.5% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $565,567, more than ten times the $23,462 reported in 2019. Among adult reconstructive orthopaedic surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,921,673in general payments, 2019–2025

Across 146 payments — averaging $13,162 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Zimmer Biomet$1.9M
Total Joint Orthopedics, Inc.$32K
Think Surgical, Inc.$12K
Smith+Nephew$738
Medacta USA, Inc.$426
Microport Orthopedics Inc$357
plus $1K from 13 others

$235,479in research payments, 2019–2025

Across 45 payments — averaging $5232.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Smith+Nephew$186K
Zimmer Biomet$47K
Orthosensor Inc.$2K

What the payments were for

Royalty or licence$1,868,36497%
Consulting fees$30,5002%
Travel & lodging$4,7910%
Food & beverage$7,9410%
Education$7,6180%
Other$2,4590%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Zimmer Biomet	63	$1,874,062
Total Joint Orthopedics, Inc.	35	$32,391
Think Surgical, Inc.	15	$12,486
Smith+Nephew	7	$738
Medacta USA, Inc.	5	$426
Microport Orthopedics Inc	2	$357
Osteoremedies, LLC	1	$217
Stryker	3	$193
Abbott	1	$164
BD	1	$158
Arthrosurface Incorporated	1	$138
Curonix LLC	1	$91
Pacira Pharmaceuticals Incorporated	3	$66
Medical Device Business Services, Inc.	2	$55
ERMI LLC	2	$37
Vertex	1	$29
Ferring Pharmaceuticals Inc.	1	$24
Convatec Inc.	1	$24
Supreme Orthopedic Systems, LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,921,673 in reported general payments places this provider in the 95th percentile of 23 adult reconstructive orthopaedic surgery providers in Georgia.

See all adult reconstructive orthopaedic surgery providers in Georgia →

Medicare billing

Part B allowed, 2024

$381,616

Medicare patients

479

Services billed

7,178

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pregabalin	196	$1,307
Diclofenac Sodium	77	$1,008
Oxycodone Hcl	271	$705
Celecoxib	23	$493
Ibuprofen	105	$468
Cefdinir	18	$290
Dexamethasone	55	$258
Amoxicillin	248	$229
Methylprednisolone	22	$96
Pantoprazole Sodium	23	$89
Tramadol Hcl	53	$80
Meloxicam	38	$68
Gabapentin	13	$54
Clindamycin Hcl	31	$48

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Atlanta

Ajay PremkumarAtlanta$99K
Greg ErensAtlanta$12K
Jeffrey PeretzAtlanta$1K
Charles ClapsNewnan$343K
Chase DeanTucker$44K
Richard BoeAustell$40K
Everett YoungWatkinsville$33K
Anthony KamsonCumming$28K
John RobisonVidalia$26K
Charlie YooRoswell$22K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →